Cancer Gene Therapy
Medulloblastoma gene therapy delivered by human neural stem cells
Published in Gene Therapy Weekly, November 16th, 2006
"Medulloblastoma, a malignant pediatric brain tumor, is incurable in about one third of patients despite multimodal treatments. In addition, current therapies can lead to long-term disabilities.
"Based on studies of the extensive tropism of neural stem cells (NSC) toward malignant gliomas and the secretion of growth factors common to glioma and medulloblastoma, we hypothesized that NSCs could target medulloblastoma and be used as a cellular...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-11-16)
More Articles from Gene Therapy Weekly
- Genetics & Genomics
Alternative splicing regulator identified by an expression cloning strategy - Pain Management
Neuropathic pain alleviated by injection of antisense oligonucleotides - RNA Interference
RNA interference library based on nuclear receptor consensus sequences reported - Vector Development
Lentiviral in situ vector delivery enabled gene transfer into adult stem cells - Angiogenesis
New angiogenesis findings from Children's Hospital described - Cancer Gene Therapy
Data on cancer gene therapy discussed by researchers at Ruhr University, Institute of Microbiology and Hygiene - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
